WO2020174288A1
|
|
Adjuvanted multivalent influenza vaccines
|
US2018207258A1
|
|
Adjuvanted influenza vaccines for pediatric use
|
EP3320343A1
|
|
Method for quantifying immunogenic hemagglutinin
|
US2018177862A1
|
|
Antigenically matched influenza vaccines
|
AU2015258263A1
|
|
Influenza virus reassortment method
|
US2017304429A1
|
|
Vaccination of immunocompromised subjects
|
AU2015203072A1
|
|
Influenza vaccine regimens for pandemic-associated strains
|
EP3131578A1
|
|
Compositions and methods to increase production
|
AU2015201871A1
|
|
Reverse genetics systems
|
AU2014203051A1
|
|
Influenza Virus Reassortment
|
US2015353900A1
|
|
Influenza virus reassortment
|
CN109045294A
|
|
Influenza virus immunization Immunogenic Compositions and its application
|
US2015315548A1
|
|
Influenza virus reassortment
|
US2013273104A1
|
|
Adjuvanted influenza vaccines for pediatric use
|
AU2013205478A1
|
|
Influenza virus reassortment
|
AU2011213757A1
|
|
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
AU2011254204A1
|
|
Influenza virus reassortment method
|
AU2010309404A1
|
|
Improved reverse genetics methods for virus rescue
|
EP2459722A1
|
|
Reverse genetics systems
|
AU2007330494A1
|
|
Vaccines including antigen from four strains of influenza virus
|